|
Real-time Estimate
Cboe BZX
02:17:28 2026-10-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 247.86 USD | -1.92% |
|
+3.09% | +41.16% |
| 02:13pm | Biogen tops quarterly estimates on rare-disease drug strength | RE |
| 10:05am | Biogen Inc., Q3 2026 Earnings Call, Oct 28, 2026 |
| Market Cap | 37.34B 33.5B 30.98B 28.05B 52.41B 3,556B 53.04B 370B 148B 1,861B 140B 137B 5,908B | P/E 2026 * |
43.3x | P/E 2027 * | 22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 42.29B 37.94B 35.08B 31.77B 59.35B 4,027B 60.07B 419B 167B 2,107B 159B 155B 6,690B | EV / Sales 2026 * |
4.05x | EV / Sales 2027 * | 3.73x |
| Free-Float |
85.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Xetra
| IDP | Delayed | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed |
Last Transcript: Biogen Inc.
| 1 day | -1.99% | ||
| 1 week | +3.09% | ||
| Current month | +9.98% | ||
| 1 month | +8.63% | ||
| 3 months | +20.82% | ||
| 6 months | +35.47% | ||
| Current year | +41.16% |
| 1 week | 240.02 |  | 258.78 |
| 1 month | 215.73 | | 258.78 |
| Current year | 160.36 | | 258.78 |
| 1 year | 138 | | 258.78 |
| 3 years | 110.04 | | 268.3 |
| 5 years | 110.04 | | 319.76 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 2022-11-13 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 2025-02-28 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 2010-03-22 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 2009-12-31 |
William Hawkins
BRD | Director/Board Member | 72 | 2019-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/2/26 | Exercice | Controller/Auditor | 62 | 0.0000% | ||
| 9/1/26 | Free | General Counsel | 7,405 | 0.0050% | ||
| 8/4/26 | Sell | Director | -593 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.92% | +3.09% | +66.58% | +4.73% | 37.34B | |
| +0.54% | +1.61% | +57.45% | +128.26% | 1,143B | |
| +1.09% | +5.16% | +45.01% | +84.36% | 647B | |
| +0.51% | +0.99% | +26.40% | +102.71% | 506B | |
| -0.05% | +1.73% | +52.74% | +65.27% | 384B | |
| -0.92% | -6.35% | +61.29% | +36.71% | 350B | |
| +0.34% | +1.84% | +30.70% | +52.69% | 293B | |
| -0.45% | +1.19% | +2.89% | +24.92% | 265B | |
| +0.66% | +2.81% | +54.29% | +71.23% | 242B | |
| +0.31% | +4.02% | +35.51% | +105.40% | 197B | |
| Average | -0.00% | +1.16% | +43.29% | +67.63% | 406.49B | |
| Weighted average by Cap. | +0.32% | +0.74% | +44.84% | +86.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.45B 9.37B 8.67B 7.85B 14.67B 995B 14.84B 104B 41.28B 521B 39.21B 38.38B 1,653B | 10.66B 9.56B 8.84B 8.01B 14.96B 1,015B 15.14B 106B 42.09B 531B 39.99B 39.14B 1,686B |
| Net income | 942M 845M 781M 708M 1.32B 89.7B 1.34B 9.34B 3.72B 46.94B 3.53B 3.46B 149B | 1.84B 1.65B 1.52B 1.38B 2.58B 175B 2.61B 18.23B 7.26B 91.6B 6.9B 6.75B 291B |
| Net Debt | 4.94B 4.44B 4.1B 3.71B 6.94B 471B 7.02B 49.04B 19.53B 246B 18.56B 18.16B 782B | 2.4B 2.15B 1.99B 1.8B 3.36B 228B 3.4B 23.77B 9.47B 119B 8.99B 8.8B 379B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | $248.31 | -1.75% | 954,030 |
| 26-10-27 | $252.73 | +0.19% | 1,393,391 |
| 26-10-26 | $252.26 | +0.63% | 958,847 |
| 26-10-23 | $250.69 | -1.24% | 1,157,376 |
| 26-10-22 | $253.84 | +5.34% | 2,237,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
